BIOCERES CROP SOLUTIONS CORP (BIOX) Stock Price, Forecast & Analysis
USA - NASDAQ:BIOX - KYG1117K1141 - Common Stock
BIOX Key Statistics, Chart & Performance
The current stock price of BIOX is 1.68 USD. In the past month the price decreased by -1.18%. In the past year, price decreased by -72.77%.
BIOX Latest News, Press Relases and Analysis
BIOX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CTVA | CORTEVA INC | 19.3 | 44.82B | ||
| CF | CF INDUSTRIES HOLDINGS INC | 10.2 | 13.77B | ||
| MOS | MOSAIC CO/THE | 10.46 | 8.27B | ||
| SMG | SCOTTS MIRACLE-GRO CO | 15.25 | 3.28B | ||
| FMC | FMC CORP | 3.92 | 1.74B | ||
| UAN | CVR PARTNERS LP | 8.24 | 1.05B | ||
| IPI | INTREPID POTASH INC | 31.19 | 348.98M | ||
| AVD | AMERICAN VANGUARD CORP | N/A | 144.42M | ||
| NITO | N2OFF INC | N/A | 2.90M |
Related stock screener links
About BIOX
Company Profile
Bioceres Crop Solutions Corp. engages in the provision of crop productivity solutions. The company is headquartered in Rosario, Santa Fe. The company went IPO on 2018-03-22. Its segments include Seed and integrated products, Crop protection and Crop nutrition. Seed and integrated products segment focuses on the development and commercialization of seed technologies and products, including provision of seed technologies integrated with crop protection and crop nutrition products designed to control weeds, insects or diseases, to increase their quality characteristics. Crop protection segment includes the development, production and marketing of adjuvants and a range of pest control molecules and biocontrol products. Crop nutrition segment focuses on the development, production and commercialization of inoculants that allow the biological fixation of nitrogen in the crops, and of fertilizers, including biofertilizers and micro-granulated fertilizers that optimize the productivity and yield of the crops.
Company Info
BIOCERES CROP SOLUTIONS CORP
Ocampo 210 bis, Predio CCT
Rosario SANTA FE 2000 AR
CEO: Federico Trucco
Employees: 389
Phone: 543414861100
BIOCERES CROP SOLUTIONS CORP / BIOX FAQ
Can you describe the business of BIOCERES CROP SOLUTIONS CORP?
Bioceres Crop Solutions Corp. engages in the provision of crop productivity solutions. The company is headquartered in Rosario, Santa Fe. The company went IPO on 2018-03-22. Its segments include Seed and integrated products, Crop protection and Crop nutrition. Seed and integrated products segment focuses on the development and commercialization of seed technologies and products, including provision of seed technologies integrated with crop protection and crop nutrition products designed to control weeds, insects or diseases, to increase their quality characteristics. Crop protection segment includes the development, production and marketing of adjuvants and a range of pest control molecules and biocontrol products. Crop nutrition segment focuses on the development, production and commercialization of inoculants that allow the biological fixation of nitrogen in the crops, and of fertilizers, including biofertilizers and micro-granulated fertilizers that optimize the productivity and yield of the crops.
What is the current price of BIOX stock?
The current stock price of BIOX is 1.68 USD. The price decreased by -1.75% in the last trading session.
What is the dividend status of BIOCERES CROP SOLUTIONS CORP?
BIOX does not pay a dividend.
What is the ChartMill rating of BIOCERES CROP SOLUTIONS CORP stock?
BIOX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the analyst forecast for BIOX stock?
10 analysts have analysed BIOX and the average price target is 5.42 USD. This implies a price increase of 222.54% is expected in the next year compared to the current price of 1.68.
What is the GICS sector and industry of BIOX stock?
BIOCERES CROP SOLUTIONS CORP (BIOX) operates in the Materials sector and the Chemicals industry.
What is the employee count for BIOX stock?
BIOCERES CROP SOLUTIONS CORP (BIOX) currently has 389 employees.
BIOX Technical Analysis
BIOX Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to BIOX. BIOX may be in some trouble as it scores bad on both profitability and health.
BIOX Financial Highlights
Over the last trailing twelve months BIOX reported a non-GAAP Earnings per Share(EPS) of -0.83. The EPS decreased by -2230.77% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -7.26% | ||
| ROE | -20.88% | ||
| Debt/Equity | 0.18 |
BIOX Forecast & Estimates
10 analysts have analysed BIOX and the average price target is 5.42 USD. This implies a price increase of 222.54% is expected in the next year compared to the current price of 1.68.
For the next year, analysts expect an EPS growth of 68.16% and a revenue growth -6.3% for BIOX